ACB: International cannabis growth drove revenue gains, but net loss rose and internal control weaknesses remain
June 11, 2026
ACBNet revenue rose to $320.6M in FY26, driven by international medical cannabis growth, while the company exited low-margin Canadian consumer and plant propagation businesses. Adjusted EBITDA improved to $53.8M, but net loss from continuing operations was $(58.6)M. Material weakness in internal controls was identified and is being remediated.
Original document: Aurora Cannabis Inc. [ACB] SEC 40-F Annual Report — Jun. 11 2026
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
© AI-generated summary is provided by Quartr
Search
RECENT PRESS RELEASES
Related Post
